open access

Vol 57, No 4 (2023)
Short Communication
Submitted: 2022-12-22
Accepted: 2023-05-11
Published online: 2023-06-21
Get Citation

Glomangioma in the hand: diagnosis, treatment, and challenges

Bartosz Szmyd1, Mikolaj Malicki1, Maciej Blaszczyk1, Filip Franciszek Karuga2, Marcin Braun3, Julia Sołek3, Redwan Jabbar1, Jakub Jankowski1, Grzegorz Wysiadecki4, Maciej Radek1
·
Pubmed: 37341191
·
Neurol Neurochir Pol 2023;57(4):387-391.
Affiliations
  1. Department of Neurosurgery, Spine and Peripheral Nerve Surgery, Medical University of Lodz, Lodz, Poland
  2. Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, Poland
  3. Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland
  4. Department of Normal and Clinical Anatomy, Medical University of Lodz, Lodz, Poland

open access

Vol 57, No 4 (2023)
Short communications
Submitted: 2022-12-22
Accepted: 2023-05-11
Published online: 2023-06-21

Abstract

Introduction. In this paper, we have analysed all hand glomangioma cases referred to our clinic in the context of symptoms, time to diagnosis, and the role of surgical resection of the lesion.

Material and methods. We have collected the following data: the presence of risk factors, manifestation, time to diagnosis, the treatment applied, and follow-up of patients.

Results. We have collected medical records from six patients, three males and three females. The median age was 45 (IQR: 29.5–65.75). The main symptom in all patients was severe pain and tenderness. The first-choice physician(s) were: general practitioners, general surgeons, and neurologists. The median time to diagnosis was 7 (IQR: 5–10) years. The main complaint of our patients was severe pain — 9 (IQR: 9–10) on the VAS scale, which was significantly alleviated after surgical treatment — 0 (IQR: 0–0; p = 0.043).

Conclusions. Extremely long times to final diagnosis, and excellent outcomes of surgical treatment, highlight the necessity of raising awareness of glomangiomas among clinicians.

Abstract

Introduction. In this paper, we have analysed all hand glomangioma cases referred to our clinic in the context of symptoms, time to diagnosis, and the role of surgical resection of the lesion.

Material and methods. We have collected the following data: the presence of risk factors, manifestation, time to diagnosis, the treatment applied, and follow-up of patients.

Results. We have collected medical records from six patients, three males and three females. The median age was 45 (IQR: 29.5–65.75). The main symptom in all patients was severe pain and tenderness. The first-choice physician(s) were: general practitioners, general surgeons, and neurologists. The median time to diagnosis was 7 (IQR: 5–10) years. The main complaint of our patients was severe pain — 9 (IQR: 9–10) on the VAS scale, which was significantly alleviated after surgical treatment — 0 (IQR: 0–0; p = 0.043).

Conclusions. Extremely long times to final diagnosis, and excellent outcomes of surgical treatment, highlight the necessity of raising awareness of glomangiomas among clinicians.

Get Citation

Keywords

subungual glomangioma, glomangioma, glomuvenous malformation, glomangiosarcoma, risk factors, treatment

Supp./Additional Files (1)
Supplementary material
Download
2MB
About this article
Title

Glomangioma in the hand: diagnosis, treatment, and challenges

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 57, No 4 (2023)

Article type

Short Communication

Pages

387-391

Published online

2023-06-21

Page views

819

Article views/downloads

571

DOI

10.5603/PJNNS.a2023.0039

Pubmed

37341191

Bibliographic record

Neurol Neurochir Pol 2023;57(4):387-391.

Keywords

subungual glomangioma
glomangioma
glomuvenous malformation
glomangiosarcoma
risk factors
treatment

Authors

Bartosz Szmyd
Mikolaj Malicki
Maciej Blaszczyk
Filip Franciszek Karuga
Marcin Braun
Julia Sołek
Redwan Jabbar
Jakub Jankowski
Grzegorz Wysiadecki
Maciej Radek

References (15)
  1. Specht K, Antonescu C. Glomus tumour. Soft Tissue Bone Tumours WHO Classif. Tumours, vol. 3. 5th ed. International Agency for Research on Cancer, Lyon 2020: 179–181.
  2. Samaniego E, Crespo A, Sanz A. [Key diagnostic features and treatment of subungual glomus tumor]. Actas Dermosifiliogr. 2009; 100(10): 875–882.
  3. Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med. 2008; 132(9): 1448–1452.
  4. Miettinen M, Paal E, Lasota J, et al. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol. 2002; 26(3): 301–311.
  5. Rössle M, Bayerle W, Löhrs U. Glomangioma of the lungs: a rare differential diagnosis of a pulmonary tumour. J Clin Pathol. 2006; 59(9): 1000.
  6. Scheithauer BW, Rodriguez FJ, Spinner RJ, et al. Glomus tumor and glomangioma of the nerve. Report of two cases. J Neurosurg. 2008; 108(2): 348–356.
  7. Wang Y, Xiang Y, Bian Y, et al. Glomus tumors associated with the bone and joints: a review of 91 cases. Ann Transl Med. 2020; 8(21): 1460.
  8. Bistazzoni S, Polosa M, Bellocchi SD. Unusual location of glomus tumors. Case Reports and Images in Surgery. 2020; 3(2).
  9. Lee TJ, Reddy GP, Leung JWT, et al. Mediastinal glomangioma: CT and octreotide scintigraphy appearance, and review of the literature. J Thorac Imaging. 2008; 23(4): 289–291.
  10. Falcone MO. Glomus tumors of the fingers. Rev Prat. 2022; 72(3): 313–316.
  11. Slater DN, Cotton DW, Azzopardi JG. Oncocytic glomus tumour: a new variant. Histopathology. 1987; 11(5): 523–531.
  12. Pulitzer D, Martin P, Reed R. Epithelioid glomus tumor. Human Pathology. 1995; 26(9): 1022–1027.
  13. Lin YC, Hsiao PF, Wu YH, et al. Recurrent digital glomus tumor: analysis of 75 cases. Dermatol Surg. 2010; 36(9): 1396–1400.
  14. Chou T, Pan SC, Shieh SJ, et al. Glomus tumor: twenty-year experience and literature review. Ann Plast Surg. 2016; 76 Suppl 1: S35–S40.
  15. Lee IJ, Park DH, Park MC, et al. Subungual glomus tumours of the hand: diagnosis and outcome of the transungual approach. J Hand Surg Eur Vol. 2009; 34(5): 685–688.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl